Sullivan Brian A, Qin Xuejun, Redding Thomas S, Gellad Ziad F, Stone Anjanette, Weiss David, Madison Ashton N, Sims Kellie J, Williams Christina D, Lieberman David, Hauser Elizabeth R, Provenzale Dawn
Cooperative Studies Program Epidemiology Center, Durham VA Health Care System, Durham, North Carolina.
Department of Medicine, Duke University, Durham, North Carolina.
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2269-2276. doi: 10.1158/1055-9965.EPI-20-0465. Epub 2020 Sep 14.
The genetic basis for most individuals with high cumulative lifetime colonic adenomas is unknown. We investigated associations between known colorectal cancer-risk single-nucleotide polymorphisms (SNP) and increasing cumulative adenoma counts.
The Cooperative Studies Program #380 screening colonoscopy cohort includes 612 selected participants age 50 to 75 with genotyped blood samples and 10 years of clinical follow-up. We evaluated 41 published "colorectal cancer-risk SNPs" for associations with individual cumulative adenoma counts or having ≥10 cumulative adenomas. SNPs were analyzed singly or combined in a polygenic risk score (PRS). The PRS was constructed from eight published SNPs associated with multiple adenomas, termed "adenoma-risk SNPs."
Four colorectal cancer-risk SNPs were associated with increasing cumulative adenoma counts ( < 0.05): rs12241008 (gene: ), rs2423279 (), rs3184504 (), and rs961253 (), with risk allele risk ratios of 1.31, 1.29, 1.24, and 1.23, respectively. Three colorectal cancer-risk SNPs were associated with ≥10 cumulative adenomas ( < 0.05), with risk allele odds ratios of 2.09 (rs3184504), 2.30 (rs961253), and 1.94 (rs3217901). A weighted PRS comprised of adenoma-risk SNPs was associated with higher cumulative adenomas (weighted rate ratio = 1.57; = 0.03).
In this mostly male veteran colorectal cancer screening cohort, several known colorectal cancer-risk SNPs were associated with increasing cumulative adenoma counts and the finding of ≥10 cumulative adenomas. In addition, an increasing burden of adenoma-risk SNPs, measured by a weighted PRS, was associated with higher cumulative adenomas.
Future work will seek to validate these findings in different populations and then augment current colorectal cancer risk prediction tools with precancerous, adenoma genetic data.
大多数累积终生结肠腺瘤患者的遗传基础尚不清楚。我们研究了已知的结直肠癌风险单核苷酸多态性(SNP)与累积腺瘤数量增加之间的关联。
合作研究项目#380结肠镜筛查队列包括612名年龄在50至75岁之间的选定参与者,他们提供了基因分型的血样并接受了10年的临床随访。我们评估了41个已发表的“结直肠癌风险SNP”与个体累积腺瘤数量或累积腺瘤≥10个之间的关联。对SNP进行单独分析或合并为多基因风险评分(PRS)。PRS由八个与多个腺瘤相关的已发表SNP构建而成,称为“腺瘤风险SNP”。
四个结直肠癌风险SNP与累积腺瘤数量增加相关(<0.05):rs12241008(基因: )、rs2423...